Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director

Published April 14, 2014

Receptos Announces Appointment of Mary Lynne Hedley, Ph.D. as Director
SAN DIEGO, April 14, 2014 (GLOBE NEWSWIRE) — Receptos, Inc. (Nasdaq:RCPT), a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Lynne Hedley, Ph.D. as …
Read more on GlobeNewswire (press release)

Heroin bill passes on unanimous vote in the Senate
The Food and Drug Administration recently approved the handheld auto-injector form of naloxone, a treatment for heroin and other opioid overdoses that could prevent deaths from overdoses. Sen. Amy Klobuchar, D-Minn., called the move an important step …
Read more on Star News

Efforts ease access to anti-overdose drug
She leaves an addiction support group clutching what she came for – Narcan, a drug often referred to as the antidote to opiate overdoses. More commonly known by its generic name, naloxone, the injectable drug reverses the potentially fatal respiratory …
Read more on Rocky Mount Telegram

Find More Drug Treatment News 2010 Information…